Morgan Stanley’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-15,826
| Closed | -$1.54M | – | 6947 |
|
|
2015
Q1 | $1.54M | Sell |
15,826
-271
| -2% | -$26.4K | ﹤0.01% | 3801 |
|
|
2014
Q4 | $1.49M | Sell |
16,097
-6,913
| -30% | -$642K | ﹤0.01% | 3802 |
|
|
2014
Q3 | $1.58M | Sell |
23,010
-4,854
| -17% | -$334K | ﹤0.01% | 3629 |
|
|
2014
Q2 | $2.92M | Buy |
27,864
+16,732
| +150% | +$1.75M | ﹤0.01% | 3175 |
|
|
2014
Q1 | $922K | Sell |
11,132
-20,292
| -65% | -$1.68M | ﹤0.01% | 4059 |
|
|
2013
Q4 | $2.03M | Buy |
31,424
+15,139
| +93% | +$980K | ﹤0.01% | 3367 |
|
|
2013
Q3 | $1.03M | Sell |
16,285
-7,784
| -32% | -$493K | ﹤0.01% | 3762 |
|
|
2013
Q2 | $1.01M | Buy |
+24,069
| New | +$1.01M | ﹤0.01% | 3726 |
|